These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24102067)

  • 61. New pharmaceuticals approved by FDA in 2020: Small-molecule drugs derived from amino acids and related compounds.
    Liu A; Han J; Nakano A; Konno H; Moriwaki H; Abe H; Izawa K; Soloshonok VA
    Chirality; 2022 Jan; 34(1):86-103. PubMed ID: 34713503
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-79. PubMed ID: 23297449
    [No Abstract]   [Full Text] [Related]  

  • 63. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
    Fed Regist; 1998 May; 63(91):26191-3. PubMed ID: 10179336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Methuselah's medicine: pharmaceutical innovation and mortality in the United States, 1960-2000.
    Schnittker J; Karandinos G
    Soc Sci Med; 2010 Apr; 70(7):961-8. PubMed ID: 20100632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fluorine in pharmaceuticals: looking beyond intuition.
    Müller K; Faeh C; Diederich F
    Science; 2007 Sep; 317(5846):1881-6. PubMed ID: 17901324
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
    O'Neill RT
    Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The FDA's generic-drug approval process: similarities to and differences from brand-name drugs.
    Kefalas CH; Ciociola AA
    Am J Gastroenterol; 2011 Jun; 106(6):1018-21. PubMed ID: 21637264
    [No Abstract]   [Full Text] [Related]  

  • 69. Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry.
    Feng M; Tang B; Liang SH; Jiang X
    Curr Top Med Chem; 2016; 16(11):1200-16. PubMed ID: 26369815
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthetic approaches to the 2004 new drugs.
    Li J; Liu KK; Sakya S
    Mini Rev Med Chem; 2005 Dec; 5(12):1133-44. PubMed ID: 16375759
    [TBL] [Abstract][Full Text] [Related]  

  • 71. U.S. FDA Approved Drugs from 2015-June 2020: A Perspective.
    Bhutani P; Joshi G; Raja N; Bachhav N; Rajanna PK; Bhutani H; Paul AT; Kumar R
    J Med Chem; 2021 Mar; 64(5):2339-2381. PubMed ID: 33617716
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.
    Johnson BM; Shu YZ; Zhuo X; Meanwell NA
    J Med Chem; 2020 Jun; 63(12):6315-6386. PubMed ID: 32182061
    [TBL] [Abstract][Full Text] [Related]  

  • 73. alpha-fluorinated ethers as "exotic" entity in medicinal chemistry.
    Jeschke P; Baston E; Leroux FR
    Mini Rev Med Chem; 2007 Oct; 7(10):1027-34. PubMed ID: 17979805
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities.
    Beierlein JM; McNamee LM; Walsh MJ; Kaitin KI; DiMasi JA; Ledley FD
    Clin Ther; 2017 Jul; 39(7):1409-1425.e20. PubMed ID: 28652015
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluorine in medicinal chemistry.
    Swallow S
    Prog Med Chem; 2015; 54():65-133. PubMed ID: 25727703
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New Approved Drugs Appearing in the Pharmaceutical Market in 2022 Featuring Fragments of Tailor-Made Amino Acids and Fluorine.
    Wang N; Mei H; Dhawan G; Zhang W; Han J; Soloshonok VA
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175060
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A review: FDA-approved fluorine-containing small molecules from 2015 to 2022.
    Sheikhi N; Bahraminejad M; Saeedi M; Mirfazli SS
    Eur J Med Chem; 2023 Nov; 260():115758. PubMed ID: 37657268
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Innovative drugs and vaccines in China, India and Brazil.
    Rezaie R; McGahan AM; Daar AS; Singer PA
    Nat Biotechnol; 2012 Oct; 30(10):923-6. PubMed ID: 23051806
    [No Abstract]   [Full Text] [Related]  

  • 79. Comparative equipment for atmospheric sampling of sulfur, fluorine, and dustfall.
    HEANEY RJ; STARR CP
    Am Ind Hyg Assoc J; 1962; 23():296-303. PubMed ID: 13905757
    [No Abstract]   [Full Text] [Related]  

  • 80. From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.
    Delost MD; Smith DT; Anderson BJ; Njardarson JT
    J Med Chem; 2018 Dec; 61(24):10996-11020. PubMed ID: 30024747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.